Every year, hundreds of women and men walk into Kenyatta National Hospital (KNH) with breast, ovarian, or prostate cancer. Some of them carry a BRCA1 or BRCA2 mutation, a genetic marker that could open the door to life-extending treatment but many may never know. The test that would tell them is cost-prohibitive, and it is not routinely offered in public hospitals in Kenya.
KAVI-ICR was pleased to host Prof. Rose Jepchumba Kosgei, newly appointed Associate Dean, Undergraduate Studies, Faculty of Health Sciences, during a courtesy visit to the Institute.
The visit brought together KAVI-ICR leadership and newly elected student leaders from the Faculty of Health Sciences and UNSA for an engaging discussion on mentorship, research exposure, academic growth and opportunities for continued collaboration.
University of Nairobi researchers and leadership joined national stakeholders at the Science, Technology, Research and Innovation for Society (STRI4Society) Week 2026 held at the Kenyatta International Convention Centre (KICC), Nairobi.
The week-long forum brought together policymakers, scientists, innovators, academia, industry and development partners to advance conversations on the role of science, research, technology and innovation in national development.
KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, is proud to highlight the participation of Prof Omu Anzala at the World Health Summit Regional Meeting 2026.
KAVI-Institute of Clinical Research, University of Nairobi, recently had the pleasure of hosting distinguished guests from the University of Gothenburg for an enriching scientific and academic engagement focused on biomedical sciences, student exchange opportunities, and international collaboration.
The recombinant protein production training workshop hosted by KAVI-Institute of Clinical Research in collaboration with BioStruct-Africa has officially commenced today at the University of Nairobi. Taking place at the Faculty of Health Sciences in Nairobi from 27 April to 2 May 2026, the week-long workshop brings together a select group of scientists for an intensive, hands-on learning experience focused on recombinant protein production.
KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, recently hosted a high-level delegation from Sanofi for an engaging visit to discuss potential pathways of collaboration and showcase the institute’s robust research capabilities across the continent.
The KAVI-Institute of Clinical Research, in collaboration with BioStruct-Africa, will host a week-long hands-on training workshop focused on recombinant protein production as a strategic tool for strengthening vaccine manufacturing capacity in Africa.
On Friday, 17th April 2026, KAVI-ICR had the privilege of hosting Dr Dipesh Solanky, MD, for a guest seminar titled:
“Molecular Diagnostics for HPV and the Role of Amplicon Sequencing toward Cervical Cancer Elimination.”
This week, KAVI–Institute of Clinical Research (KAVI-ICR), University of Nairobi, in partnership with ClinWin Research Services, is hosting a high-impact Clinical Trial Monitoring Course in Nairobi, bringing together early-career and experienced professionals from across the region. The course is part of a long-standing collaboration between KAVI-ICR and ClinWin focused on strengthening Africa’s clinical research ecosystem through practical, skills-based training and mentorship.
